Publications by authors named "Claudia Boldrin"
Int J Cardiol
January 2024
Article Synopsis
- * It compared two groups: patients treated from 2007-2012 (old treatments) and those treated from 2013-2020 (new treatments), finding that the newer treatments significantly reduced the risk of adverse events and 5-year mortality.
- * Key factors for improved outcomes included the use of newer drugs like prasugrel or ticagrelor and complete revascularization, leading to lower risks of complications such as stent thrombosis.
